Medline Inc. (MDLN): Cost of Revenue

Annual figures by period end, from SEC filings.

$20.91B

Year ended 2025-12-31

$22.09B

Trailing 12 months to 2026-06-27

2023-12-31 Cost of Revenue (USD) 2025-12-31

Period ended	Cost of Revenue	Change YoY	Source filing
2025-12-31	$20.91B	+12.9%	2026-02-25, From 2025-01-01
2024-12-31	$18.53B	+6.8%	2026-02-25, From 2024-01-01
2023-12-31	$17.35B	n/a	2026-02-25, From 2023-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Cost of Revenue	Change YoY
Medline Inc. (MDLN)	2025-12-31	$20.91B	+12.9%
Stryker Corp (SYK)	2025-12-31	$9.05B	+11.0%
3M Co (MMM)	2025-12-31	$14.99B	+3.8%
Becton Dickinson & Co (BDX)	2025-09-30	$11.91B	+7.8%
Boston Scientific Corp (BSX)	2025-12-31	$6.22B	+18.3%
Baxter International Inc (BAX)	2025-12-31	$7.87B	+18.2%
ResMed Inc (RMD)	2026-06-30	$2.20B	+5.3%
Dexcom Inc (DXCM)	2025-12-31	$1.86B	+16.6%
MiniMed Group, Inc. (MMED)	2026-04-24	$1.42B	+19.8%

Compare MDLN, SYK, MMM, BDX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗